#BEGIN_DRUGCARD DB01975

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H25N5O13P2

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4S,5S)-3,4,5-trihydroxyoxolan-2-yl]methoxy})phosphoryl]methyl})phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
AMPCPR

# HET_ID:
ADV

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H25N5O13P2/c17-13-8-14(19-3-18-13)21(4-20-8)15-11(24)9(22)6(33-15)1-31-35(27,28)5-36(29,30)32-2-7-10(23)12(25)16(26)34-7/h3-4,6-7,9-12,15-16,22-26H,1-2,5H2,(H,27,28)(H,29,30)(H2,17,18,19)/t6-,7+,9-,10+,11+,12-,15+,16-/m0/s1

# InChI_Key:
InChIKey=ZPZRETFSCSWNDT-VXLWFBCLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1975

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
557.3429

# Molecular_Weight_Mono:
557.092408935

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KHZ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
4.24e+00 g/l

# Primary_Accession_No:
DB01975

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936273

# PubChem_Substance_ID:
46508105

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00439

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@@](O)(=O)C[P@](O)(=O)OC[C@H]2O[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
alpha-beta methylene adp-ribose

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:40 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE005674

# Drug_Target_1_GenBank_ID_Protein:
24053496

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nudF

# Drug_Target_1_Gene_Sequence:
>630 bp
TTATGCCCACTCATTTTTTAACGCTTGATGATGCAGCTGCAGCCATTGCAAAGCGATGAC
CGACGCTGCGTTGTCGATTTTCCCCTCTTCTACCCACTGGTATGCCTGTTCCCGGCTTAC
CACATGAACGCGAATATCTTCGTTTTCATCAGCCAGACCATGAATACCGCTTGCGGTCGT
GGCGTCCACTTCGCCCACCATAATTGACGAACGCTCACTGGTGCCCCCCGGGCTTGCCAG
GAAACTTAACACCGGTTTGGTCCGTTTGACTATCAGTCCCGCCTCTTCAATCGCTTCGCG
ACGGGCAACATCTTCCACACTTTCACCCTCTTCAATCATCCCGGCAACCATCTCCAGTAG
CCAGGGGGTTTCGCTGGTGTCGTACGCGGCAATCCGAATCTGCTCAATCAGCACAACTTC
ATCACGCACTGGGTCAAAGGGTAGCAAGACTGCGGCGTGACCGCGCTCAAAAATTTCCCG
CCGTACCTCATGACTCATTTGCCCGTTGAATAGACGATGACGAAATCTATAAAGATCTAA
TGAAAAAAAGCCGCGATAAAGTGTTTCTCGTGCAATAATTTCTACATCGTTTTTGCCAAA
TGTAACGGGCAGGTTGTCTGGCTTAAGCAT

# Drug_Target_1_General_Function:
Replication, recombination and repair

# Drug_Target_1_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2460

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
23667

# Drug_Target_1_Name:
ADP-ribose pyrophosphatase

# Drug_Target_1_Number_of_Residues:
209

# Drug_Target_1_PDB_ID:
1G0S

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00293	NUDIX

# Drug_Target_1_Protein_Sequence:
>ADP-ribose pyrophosphatase
MLKPDNLPVTFGKNDVEIIARETLYRGFFSLDLYRFRHRLFNGQMSHEVRREIFERGHAA
VLLPFDPVRDEVVLIEQIRIAAYDTSETPWLLEMVAGMIEEGESVEDVARREAIEEAGLI
VKRTKPVLSFLASPGGTSERSSIMVGEVDATTASGIHGLADENEDIRVHVVSREQAYQWV
EEGKIDNAASVIALQWLQLHHQALKNEWA

# Drug_Target_1_Reaction:
ADP-ribose + H2O = AMP + D-ribose 5-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acts on ADP-mannose and ADP-glucose as well as ADP- ribose. Prevents glycogen biosynthesis. The reaction catalyzed by this enzyme is a limiting step of the gluconeogenic process

# Drug_Target_1_SwissProt_ID:
P83844

# Drug_Target_1_SwissProt_Name:
ADPP_SHIFL

# Drug_Target_1_Synonyms:
ADP-ribose diphosphatase
ADP-ribose phosphohydrolase
ADPR-PPase
ASPPase
Adenosine diphosphoribose pyrophosphatase
EC 3.6.1.13

# Drug_Target_1_Theoretical_pI:
4.72

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BX842577

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
MT1739

# Drug_Target_2_Gene_Sequence:
>624 bp
GTGGCTGAGCATGATTTCGAGACGATATCGTCGGAAACCTTGCATACGGGAGCCATTTTC
GCATTACGTCGGGACCAGGTGCGGATGCCTGGTGGGGGTATTGTGACGCGTGAGGTCGTC
GAGCACTTCGGTGCCGTAGCCATTGTGGCGATGGACGACAACGGCAACATCCCGATGGTT
TATCAGTACCGCCACACCTATGGTCGGCGGCTTTGGGAACTGCCCGCGGGGTTGCTCGAC
GTCGCTGGGGAGCCACCTCATCTCACGGCCGCCCGGGAGCTGCGGGAGGAGGTCGGGCTG
CAAGCCAGCACCTGGCAGGTGCTGGTCGATCTGGACACCGCGCCGGGCTTCAGCGACGAA
TCGGTGCGGGTCTATCTGGCCACCGGACTGCGCGAGGTGGGCCGGCCCGAAGCCCATCAC
GAAGAAGCCGACATGACGATGGGGTGGTATCCCATTGCCGAAGCGGCTCGCCGGGTGCTG
CGTGGCGAAATCGTCAATTCCATTGCCATTGCCGGTGTTTTGGCCGTGCACGCGGTGACG
ACCGGGTTCGCCCAGCCACGCCCACTCGATACCGAATGGATCGACAGGCCAACGGCGTTC
GCCGCGCGGAGAGCCGAGCGATGA

# Drug_Target_2_General_Function:
Involved in hydrolase activity

# Drug_Target_2_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4555

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
22893

# Drug_Target_2_Name:
Hypothetical protein

# Drug_Target_2_Number_of_Residues:
207

# Drug_Target_2_PDB_ID:
1MR2

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00293	NUDIX

# Drug_Target_2_Protein_Sequence:
>Hypothetical protein
MAEHDFETISSETLHTGAIFALRRDQVRMPGGGIVTREVVEHFGAVAIVAMDDNGNIPMV
YQYRHTYGRRLWELPAGLLDVAGEPPHLTAARELREEVGLQASTWQVLVDLDTAPGFSDE
SVRVYLATGLREVGRPEAHHEEADMTMGWYPIAEAARRVLRGEIVNSIAIAGVLAVHAVT
TGFAQPRPLDTEWIDRPTAFAARRAER

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
O33199

# Drug_Target_2_SwissProt_Name:
O33199_MYCTU

# Drug_Target_2_Synonyms:
MutT/nudix family protein

# Drug_Target_2_Theoretical_pI:
5.12

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB01975
